TRC 2XXX
Latest Information Update: 22 Nov 2019
At a glance
- Originator Torrent Pharmaceuticals
- Class Ischaemic heart disorder therapies; Vasodilators
- Mechanism of Action Nitric oxide donors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Angina pectoris
Most Recent Events
- 22 Nov 2019 Discontinued - Preclinical for Angina pectoris in India (unspecified route)
- 10 Sep 2002 TRC 2XXX is available for licensing in the USA, Europe and Japan [http://www.torrent-india.com]
- 10 Sep 2002 Preclinical trials in Angina pectoris in India (unspecified route)